FDA 2018: Busy Busy
Last year was unquestionably an excellent year from an FDA NCE approval perspective. A recent article in Nature Reviews Drug Discovery has the full list. An interactive table (complete with…
Last year was unquestionably an excellent year from an FDA NCE approval perspective. A recent article in Nature Reviews Drug Discovery has the full list. An interactive table (complete with…
That didn't take long. In mid-December, we released a short video that summarized a few items of interest from 2018. We also offered a few predictions for 2019. One of…